24-06-2026 19:58 via medpagetoday.com

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

(MedPage Today) -- Topline data showed that a single dose of an investigational LSD-based pill (DT120) met primary and key secondary endpoints in a phase III trial of adults with major depressive disorder, developer Definium Therapeutics said...
Read more »

Medical Industry news



Long-Term CAR-T Results in Lymphoma Confirm Early Promise
ALS Testing Expected to Drive Sharp Rise in Clinic Visits
Midterm TAVR Data Turn Muddy: Will 10 Years Even Suffice for a Verdict?
Health Spending Projected to Hit Almost $9 Trillion in 2034
Few IVF Add-Ons Have Any Proven Benefits, Study Shows
South African Civil Groups Warn of Dire Impact as U.S. Phases Out HIV Funding
Shorter TB Regimen Matched Standard Care in Rifampicin-Resistant Disease
FDA Approves CDK4/6 Inhibitor for HER2-Positive Breast Cancer
Can Advanced MRI Personalize Radiation for Glioblastoma?
Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk
Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day
Nature Retracts Cancer Study Linking Treatment Timing to Survival
How a Drug With More Negative Than Positive Studies Won FDA Approval
Could TILs Serve as a Marker of Immunotherapy Benefit in Early TNBC?
Desktop versie